Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for reducing blood sugar and blood fat and application thereof

A composition and a hypoglycemic technology, applied in the field of medicine, can solve problems such as unsatisfactory treatment effect, and achieve the effect of reducing content and improving treatment effect

Inactive Publication Date: 2018-03-09
GUILIN HAOXIN TECH SERVICE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Due to age factors, pathological factors, eating habits and other reasons, most diabetic patients do not use drugs to maintain normal or near-normal levels of blood sugar and blood lipids. Although there are some reports about drugs that lower blood sugar and blood lipids, but The treatment effect is not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Formula composition: in parts by weight, 25 parts of acipimox, 20 parts of Zhibituo, 15 parts of metformin hydrochloride, 30 parts of acarbose, 100 parts of starch, 100 parts of microcrystalline cellulose, 70 parts of sodium carboxymethyl starch part, 2-5 parts of magnesium stearate.

[0017] Coating Solution Prescription: Povidone K 30 aqueous solution.

[0018] The preparation method of the tablet: take acipimox, Zhibituo, sodium carboxymethyl starch, and microcrystalline cellulose of the prescribed amount and mix them evenly, then mix them with the prescribed amount of metformin hydrochloride and acarbose, and mix them with polyvinyl chloride Ketone K 30 The aqueous solution is used as a binder to make a soft material, granulated; dried;

Embodiment 2

[0020] Formula composition: in parts by weight, 35 parts of acipimox, 24 parts of Zhibituo, 20 parts of metformin hydrochloride and 40 parts of acarbose, 100 parts of starch, 100 parts of microcrystalline cellulose, 70 parts of sodium carboxymethyl starch part, 2-5 parts of magnesium stearate.

[0021] Coating Solution Prescription: Povidone K 30 aqueous solution.

[0022] The preparation method of the tablet: take acipimox, Zhibituo, sodium carboxymethyl starch, and microcrystalline cellulose of the prescribed amount and mix them evenly, then mix them with the prescribed amount of metformin hydrochloride and acarbose, and mix them with polyvinyl chloride Ketone K 30 The aqueous solution is used as a binder to make a soft material, granulated; dried;

Embodiment 3

[0024] Formula composition: in parts by weight, 25 parts of acipimox, 20 parts of Zhibituo, 15 parts of metformin hydrochloride, 30 parts of acarbose, 100 parts of starch, 100 parts of microcrystalline cellulose, 70 parts of sodium carboxymethyl starch part, 2-5 parts of magnesium stearate.

[0025] Coating Solution Prescription: Povidone K 30 aqueous solution.

[0026] The preparation method of the tablet: take acipimox, Zhibituo, sodium carboxymethyl starch, and microcrystalline cellulose of the prescribed amount and mix them evenly, then mix them with the prescribed amount of metformin hydrochloride and acarbose, and mix them with polyvinyl chloride Ketone K 30 The aqueous solution is used as a binder to make a soft material, granulated; dried;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for reducing blood sugar and blood fat and an application thereof. The pharmaceutical composition comprises the following effective active ingredients: acipimox, Zhibituo, melbine and acarbose. According to the pharmaceutical composition, the shortage of non-ideal effect of drugs in reducing blood sugar and blood fat in the prior art can be effectively solved; in addition, the abovementioned drugs are combined to use to realize synergistic interaction, rather than simple overlapping of the effects. The pharmaceutical composition is capableof improving the effect on treating diabetes, as well as reducing the content of triglyceride in a human body.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for lowering blood sugar and blood fat and its application. Background technique [0002] Diabetes is a group of metabolic disorders characterized by elevated blood glucose levels due to relative or absolute insufficiency of insulin in the body, including sugar, fat, and protein metabolic disorders and the resulting tissue and organ dysfunction; persistent high blood sugar is a basic biochemical characteristics, but accompanied by hyperlipidemia and other metabolic disorders. Hyperlipidemia is one of the important risk factors of arteriosclerosis and coronary heart disease, and is the pathological basis of cardiovascular and cerebrovascular diseases. Most diabetic patients are accompanied by hyperlipidemia in varying degrees. If the metabolic disorder cannot be corrected in time and the blood sugar and blood lipids can be lowered to normal levels, i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P3/06A61P3/10A61P9/10A61K36/062A61K31/4965A61K31/155A61K31/7036
CPCA61K36/899A61K31/155A61K31/4965A61K31/7036A61K36/062A61K2236/19A61K2300/00
Inventor 钟传新王君
Owner GUILIN HAOXIN TECH SERVICE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com